OptimizeRx Corp·4

Feb 20, 1:39 PM ET

Besch Doug 4

4 · OptimizeRx Corp · Filed Feb 20, 2025

Insider Transaction Report

Form 4
Period: 2025-02-15
Besch Doug
Chief Product Officer
Transactions
  • Tax Payment

    Common Stock

    2025-02-15$6.64/sh1,386$9,20351,605 total
Footnotes (1)
  • [F1]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

Documents

1 file
  • 4
    wk-form4_1740076778.xmlPrimary

    FORM 4